- Home
- MUX vs DNTH Comparison
MUX vs DNTH Comparison
Compare MUX & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MUX | DNTH |
|---|---|---|
| Founded | 1979 | 2015 |
| Country | Canada | United States |
| Employees | 1432 | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.9B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | MUX | DNTH |
|---|---|---|
| Price | $19.45 | $79.52 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 12 |
| Target Price | $26.63 | ★ $123.09 |
| AVG Volume (30 Days) | 1.0M | ★ 1.1M |
| Earning Date | 03-12-2026 | 03-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,036,000.00 |
| Revenue This Year | $22.52 | N/A |
| Revenue Next Year | $26.24 | $30.33 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.38 | $13.37 |
| 52 Week High | $29.70 | $88.45 |
Technical Indicators
Market Signals| Indicator | MUX | DNTH |
|---|---|---|
| Relative Strength Index (RSI) | 34.24 | 67.56 |
| Support Level | $17.70 | $33.94 |
| Resistance Level | $20.59 | $88.45 |
| Average True Range (ATR) | 1.31 | 4.89 |
| MACD | -0.62 | -0.34 |
| Stochastic Oscillator | 15.48 | 68.76 |
Price Performance
Historical ComparisonAbout MUX McEwen Mining Inc.
McEwen Inc, formerly McEwen Mining Inc is a mining and minerals production and exploration company that focuses on precious and base minerals in Argentina, Mexico, and the United States. The company generates its revenue from gold and silver production. It owns and operates the wholly-owned El Gallo 1 mine in Mexico and holds a minority stake in the company that manages the San Jose mine in Argentina. More than half of the company's gold output comes from the El Gallo 1 mine, while the remaining gold production and the majority of silver production are sourced from the San Jose mine. Geographically, majority of production occurs in the United States.
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.